Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 204 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$166.4M
Avg Funding
$41.6M
Cities
4

Export 204 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Saint Laurent, Canada
$101.2M
raised

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oslo, Norway
$32.3M
raised

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$7.9M
raised

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$25.0M
raised

Clever Leaves is a multi-national operator (MNO) and a licensed producer of pharmaceutical-grade medical cannabis.

Jul 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 201 to 204 of 204 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked